Stockscreener 앱 받기
0.95
0.00%
0.00
Telesis Bio Inc (TBIO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
50.70%
3.44
|
6.977 | 5.564 | 8.652 | 6.316 |
| Cost Of Revenue |
10.50%
1.994
|
2.228 | 2.567 | 2.959 | 2.805 |
| Gross Profit |
69.55%
1.446
|
4.749 | 2.997 | 5.693 | 3.511 |
Operating Expenses
|
55.16%
9.967
|
22.23 | 13.12 | 13.66 | 14.48 |
| Interest Income/Expense |
0.217
|
- | - | - | - |
| Benefits Costs and Expenses |
51.04%
12.07
|
24.66 | 16.18 | 16.93 | 17.43 |
| Costs And Expenses |
51.04%
12.07
|
24.66 | 16.18 | 16.93 | 17.43 |
| Provision For Loan, Lease, And Other Losses |
0.023
|
- | - | - | - |
| Operating Income/Loss |
51.26%
-8.521
|
-17.48 | -10.12 | -7.966 | -10.97 |
| Nonoperating Income/Loss |
43.84%
-0.114
|
-0.203 | -0.496 | -0.317 | -0.145 |
| Income/Loss From Continuing Operations Before Tax |
51.17%
-8.635
|
-17.68 | -10.62 | -8.283 | -11.12 |
| Income Tax Expense/Benefit |
33.33%
0.002
|
0.003 | 0.014 | 0.004 | 0.003 |
| Income/Loss From Continuing Operations After Tax |
51.17%
-8.637
|
-17.69 | -10.63 | -8.287 | -11.12 |
|
Net Income/Loss
|
51.17%
-8.637
|
-17.69 | -10.63 | -8.287 | -11.12 |
| Preferred Stock Dividends And Other Adjustments |
1.04%
0.585
|
0.579 | 0.568 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,988%
1.671
|
0.0541 | 29.95 | 29.77 | 29.66 |
| Diluted Average Shares |
2,988%
1.671
|
0.0541 | 29.95 | 29.77 | 29.66 |
| Basic Earnings Per Share |
804.92%
-5.52
|
-0.61 | -0.37 | -0.28 | -0.37 |
| Diluted Earnings Per Share |
804.92%
-5.52
|
-0.61 | -0.37 | -0.28 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
1.04%
0.585
|
0.579 | 0.568 | - | - |
1.38%
0.43%
자본화:
|
볼륨(24시간):